慢性硬膜下血肿的脑膜中动脉栓塞治疗在分流后正常压力脑积水患者中的应用
本研究比较了分流后正常压力脑积水合并慢性硬膜下血肿患者接受标准治疗(分流调整±钻孔引流)与加用脑膜中动脉栓塞(MMA-E)的效果。结果显示MMA-E组7例中6例血肿消退,但消退速度未较标准治疗加快,作者认为该队列中广泛使用MMA-E需进一步研究。
要点
- 分流后正常压力脑积水患者因过度引流易发生慢性硬膜下血肿。
- MMA-E组7例中6例血肿消退,1例残留3 mm稳定血肿。
- MMA-E未显示较标准治疗加快血肿消退速度。
核心结论
- MMA-E在分流导致的慢性硬膜下血肿中未显示较标准治疗加快消退速度,该队列中广泛使用MMA-E需进一步研究。
研究设计与样本
- 本研究中心经验系列,比较9例接受标准治疗(分流调整伴或不伴钻孔引流)与7例接受标准治疗联合MMA-E的正常压力脑积水、脑室腹腔分流及分流所致慢性硬膜下血肿患者,血肿大小和年龄匹配,系列头部CT随访。
主要发现
- MMA-E组7例中6例血肿消退,1例在重新启动脑积水治疗后残留但稳定的3 mm慢性硬膜下血肿。
- 中位消退时间:未手术的标准治疗为139.5天,手术的标准治疗为89天;未手术的标准治疗联合MMA-E为309天,手术的标准治疗联合MMA-E为88天。
- 1例MMA-E患者失访,超过一年后就诊时血肿减小,于MMA-E后第504天消退。
临床怎么用
- 作者认为该队列中广泛使用MMA-E需进一步研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shunted hydrocephalus patients are at an inherent risk of developing chronic subdural hematomas (cSDHs) from overdrainage. The preliminary results of three much-anticipated clinical trials (STEM, EMBOLISE, MAGIC-MT) have recently been presented, showing efficacy of middle meningeal artery embolization (MMA-E) in reducing observational failure and the need for reoperation in non-shunted patients, but the effect of this procedure in shunted patients remains to be further investigated. In this series, we present our institution's experience with MMA-E in shunted normal pressure hydrocephalus patients in comparison to standard of care (=SOC). METHODS: We compared nine patients with normal pressure hydrocephalus, ventriculoperitoneal shunt, and shunt-induced cSDHs receiving SOC, shunt adjustment with or without burr hole drainage, to seven patients receiving SOC with MMA-E. Hematoma size and age of patients were matched. Patients were followed with serial head computed tomography scans. Symptoms, hematoma size, time to resolution, resolution status, and embolization details were monitored. RESULTS: Six of seven SDH patients receiving MMA-E resolved. One patient showed residual but stable 3 mm cSDH after reinitiation of hydrocephalus treatment. The median time to resolution was 139.5 and 89 days for SOC without and with surgery, and 309 or 88 days for SOC without and with surgery plus MMA-E. One MMA-E patient was lost to follow-up and presented more than one year later with decreasing SDH that resolved by post-MMA-E day 504. CONCLUSIONS: MMA-E in shunt-induced cSDHs has not shown increased resolution speed compared to SOC and liberal use of MMA-E on this cohort may need to be further investigated.
引用
- Meggyesy M, Xia Y, Williams G, et al. Middle Meningeal Artery Embolization in Chronic Subdural Hematoma in Post Shunted Normal Pressure Hydrocephalus. World Neurosurg. 2025. PMID: 39675669. doi:10.1016/j.wneu.2024.123576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。